indication
as of 2026-07-01Neurobehavioral Manifestations
Competitive landscape projected to Berberine’s launch window
Competitive set
1
0 approved · 1 pipeline
Projection timeline
actual past → guided future · protection walls overlaid
2 events
2018
2020
2022
2024
2026
2028
2030
today
Berberine launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff
Competitive set
resolved drugs with trials in this indicationdrugCompleted
Pipeline · Phase 3
Phase 32 trials
Protection—
Market size
prevalence as a range, not a number